Abilify and Peridex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Peridex (chlorhexidine gluconate). Common drug interactions include constipation among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Peridex. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,455 Abilify users. Check the latest studies of Abilify.

What is Peridex?

Peridex has active ingredients of chlorhexidine gluconate. eHealthMe is studying from 2,803 Peridex users. Check the latest studies of Peridex.



On Aug, 12, 2026

29 people who take Abilify and Peridex together, and have interactions are studied.

Abilify and Peridex drug interactions.

What are the common drug interactions of Abilify and Peridex, by gender? *:

female:

  1. Constipation
  2. Exposed bone in jaw
  3. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  4. Hypertension (high blood pressure)
  5. Insomnia (sleeplessness)
  6. Osteonecrosis of jaw (death of bone of jaw)
  7. Pleural effusion (water on the lungs)
  8. Urinary tract infection
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Cellulitis (infection under the skin)

male:

  1. Anxiety
  2. Back pain
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Cellulitis (infection under the skin)
  5. Constipation
  6. Cystitis (inflammation of the wall of the bladder)
  7. Exostosis (formation of new bone on the surface of a bone)
  8. Exposed bone in jaw
  9. Fall
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Abilify and Peridex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anxiety
  2. Pain
  3. Epistaxis (bleed from the nose)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Compulsive sexual behaviour (unable to manage his/her sexual behaviour)
  6. Compulsive shopping
  7. Disability
  8. Eating disorder
  9. Emotional distress
  10. Impulse-control disorder

40-49:

  1. Cardiac arrest
  2. Cardiac disorder
  3. Lethargy (tiredness)
  4. Maternal exposure during pregnancy (use of substance during pregnancy)
  5. Oxygen saturation decreased
  6. Premature delivery
  7. Pulmonary hypertension (increase in blood pressure in the lung artery)
  8. Respiratory depression (respiration has a rate below 12 breaths)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Respiratory rate decreased (less breathing rate/min)

50-59:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  4. Blood cholesterol increased
  5. Cardiac failure congestive
  6. Cardiac murmur (an heart sound in valve abnormality)
  7. Cardiomyopathy (weakening of the heart muscle)
  8. Cluster headache (one-sided head pain with tearing)
  9. Coma (state of unconsciousness lasting more than six hours)
  10. Constipation

60+:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  2. Pneumonia
  3. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  4. Arthralgia (joint pain)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Asthma
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Back pain
  9. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  10. Blepharitis (chronic inflammation of the eyelid)

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 12 people, 41.38%
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints): 8 people, 27.59%
  3. Breast Cancer: 4 people, 13.79%
  4. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 4 people, 13.79%
  5. Bipolar Disorder (mood disorder): 4 people, 13.79%
  6. Stress And Anxiety: 3 people, 10.34%
  7. Ovarian Cancer (cancer of ovary): 3 people, 10.34%
  8. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 10.34%
  9. Post-Traumatic Stress Disorder: 2 people, 6.90%
  10. Pain: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Peridex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Peridex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Peridex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Peridex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and chlorhexidine gluconate (the active ingredients of Abilify and Peridex, respectively), and Abilify and Peridex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: